Details for New Drug Application (NDA): 020089
✉ Email this page to a colleague
The generic ingredient in ZOVIRAX is acyclovir sodium. There are fifty-six drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the acyclovir sodium profile page.
Summary for 020089
Tradename: | ZOVIRAX |
Applicant: | Norvium Bioscience |
Ingredient: | acyclovir |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 020089
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 400MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Apr 30, 1991 | TE: | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 800MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Apr 30, 1991 | TE: | RLD: | Yes |
Expired US Patents for NDA 020089
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Norvium Bioscience | ZOVIRAX | acyclovir | TABLET;ORAL | 020089-001 | Apr 30, 1991 | ⤷ Sign Up | ⤷ Sign Up |
Norvium Bioscience | ZOVIRAX | acyclovir | TABLET;ORAL | 020089-002 | Apr 30, 1991 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription